Resource use and cost analysis of managing abnormal Pap smears: A retrospective study in five countries

European Journal of Gynaecological Oncology

Volumn 29, Issue 3, 2008, Pages 225-232

  Rash, B ^a   Martin Hirsch, P ^b   Schneider, A ^c   Sideri, M ^d   Tan, J ^e   Torne A ^f   Standaert, B ^g,h  

^a Health Market International   (United States)

^b ROYAL PRESTON HOSPITAL   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e ROYAL WOMEN'S HOSPITAL   (Australia)

^f HOSPITAL CLÍNIC   (Spain)

^g Health Economics   (Belgium)

^h GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Cervical cancer; Cervical cytology; Cost analysis; HPV; Pap smear; Screening

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA COLLECTION METHOD; DISEASE SEVERITY; FEMALE; GERMANY; HISTOLOGY; HUMAN; ITALY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PUBLIC HEALTH; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; SCREENING; SPAIN; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

AUSTRALIA; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; COSTS AND COST ANALYSIS; EUROPE; FEMALE; HEALTH RESOURCES; HUMANS; MASS SCREENING; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 44349116054     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Anttila A., Ronco G., Clifford G., Bray F., Hakama M., Arbyn M., et al.: "Cervical cancer screening programmes and policies in 18 European countries". Br. J. Cancer, 2004, 91, 935.
2. Apgar B.S., Brotzman G.: "Management of cervical cytologic abnormalities". Am. Fam. Phys., 2004, 70, 1905.
3. Kocjan G., Priollet B.C., Desai M., Koutselini H., Mahovlic V., Oliveira M.H. et al.: "BSCC, Bethesda or other? Terminology in cervical cytology European panel discussion". Cytopathology, 2005, 16, 113.
4. Syrjanen K.J.: "Management of Abnormal Pap Smears (MAPS): Implications of Terminology Used in Cytopathology". J. Lower Gen. Tract Dis., 2000, 4, 217.
5. Bell S., Porter M., Kitchener H., Fraser C., Fisher P., Mann E.: "Psychological response to cervical screening". Prev. Med., 1995, 24, 610.
6. Freeman-Wang T., Walker P., Linehan J., Coffey C., Glasser B., Sherr L.: "Anxiety levels in women attending colposcopy clinics for treatment for cervical intraepithelial neoplasia: a randomised trial of written and video information". BJOG, 2001, 108, 482.
7. Fylan F.: "Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour". Br. J. Gen. Pract., 1998, 48, 1509.
8. van Ballegooijen M., van den Akker-van Marle E., Patnick J., Lynge E., Arbyn M., Anttila A. et al.: "Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness". Eur. J. Cancer, 2000, 36, 2177.
9. van Ballegooijen M., Habbema J.D., van Oortmarssen G.J., Koopmanschap M.A., Lubbe J.T., van Agt H.M.: "Preventive Papsmears: balancing costs, risks and benefits". Br. J. Cancer, 1992, 65, 930.
10. Kaminsky F.C., Benneyan J.C., Mullins D.L.: "Automated rescreening in cervical cytology. Mathematical models for evaluating overall process sensitivity, specificity and cost". Acta Cytol., 1997, 41, 209.
11. van den Akker-van Marle M.E., van Ballegooijen M., van Oortmarssen G.J., Boer R., Habbema J.D.: "Cost-effectiveness of cervical cancer screening: comparison of screening policies". J. Natl. Cancer Inst., 2002, 94, 193.
12. Wright T.C. Jr., Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J.: "2001 Consensus Guidelines for the management of women with cervical cytological abnormalities". JAMA, 2002, 287, 2120.
13. Wolstenholme J.L., Whynes D.K.: "Stage-specific treatment costs for cervical cancer in the United Kingdom". Eur. J. Cancer, 1998, 34, 1889.
14. Bergeron C., Benard S., Bouee S., Breugelmans G.: "Cervical cancer screening and treatment costs in France". Eur. J. Obstet. Gynecol. Reprod. Biol., 2006.
15. Brown R.E., Bruegelmans J.G., Theodoratou D., Bénard S.: "Cost of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK". Curr. Med. Res. Opin., 2006, 22, 663.
16. Insinga R.P., Glass A.G., Rush B.B.: "The health care costs of cervical human papillomavirus-related disease". Am. J. Obstet. Gynecol., 2004, 191, 114.
17. Goldie S.J.: "Health economics and cervical cancer prevention: a global perspective". Virus Res., 2002, 89, 301.
18. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M. et al.: "The 2001 Bethesda System: terminology for reporting results of cervical cytology". JAMA, 2002, 287, 2114.
19. Evans D.M., Hudson E.A., Brown C.L., Boddington M.M., Hughes H.E., Mackenzie E.F. et al.: "Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology". J. Clin. Pathol., 1986, 39, 933.
20. Soost H.J.: "The Munich nomenclature". Recent Results Cancer Res., 1993, 133, 105.
21. Terminology. Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities. Canberra: National Health and Medical Research Council, 2005, 19.
22. Purchasing power parities. OECD 2007 [cited 2007 Jan]; Available from: URL: http://www.oecd.org/document/47/0,2340,en_2649_201185_36202863_1_1_1_1,00. html#ppp.
23. Kim J.J., Leung G.M., Woo P.P., Goldie S.J.: "Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong". J. Public Health (Oxf.), 2004, 26, 130.
24. Dvorak K.A., Finnemore M., Maksem J.A.: "Histology correlation with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) cytology diagnoses: An argument to ensure ASCUS follow-up that is as aggressive as that for LSIL". Diagn. Cytopathol., 1999, 21, 292.
25. McCrory D.C., Matchar D.B., Bastian L., Datta S., Hasselblad V., Hickey J. et al.: "Evaluation of cervical cytology". Evid. Rep. Technol. Assess. (Summ.), 1999, 5, 1.
26. Noller K.L.: "Cervical cytology screening and evaluation". Obstet. Gynecol., 2005, 106, 391.
27. Renshaw A.A.: "Measuring sensitivity in gynecologic cytology: a review". Cancer, 2002, 96, 210.
28. Cuzick J., Clavel C., Petry K.U., Meijer C.J., Hoyer H., Ratnam S. et al.: "Overview of the European and North American studies on HPV testing in primary cervical cancer screening". Int. J. Cancer, 2006, 119, 1095.
29. Mahdavi A., Monk B.J.: "Vaccines against human papillomavirus and cervical cancer: promises and challenges". Oncologist, 2005, 10, 528.
30. Nuovo J., Melnikow J., Howell L.P.: "New tests for cervical cancer screening". Am. Fam. Phys., 2001, 64, 780.